• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

CLOUDBREAK-B(02592.HK)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Jan2
Fortus Holdings Extends Lock-Up Period Commitment for Pullcom Eye Cloud-B's Issued Shares
04:17
Dec15
Puckcom Vision Cloud-B Submits CBT-199 New Drug Clinical Trial Application
09:17
Dec12
Cloudbreak USA held a Phase 2 Clinical Trial Meeting with FDA for CBT-004
08:38
Dec8
Cloudbreak USA to Hold Post-Phase 2 Clinical Trial Meeting with FDA
04:24
Nov26
KonSiYun Shares Latest Clinical Progress of CBT-001 and CBT-004 at Ophthalmic Innovation Summit
07:37
Aug29
CLOUDBREAK-B released FY2025 Semi-Annual Earnings on August 29 BJT with actual revenue HKD 0 and actual EPS HKD -0.3346
15:00

Schedules & Filings

Schedules
Filings
Aug29
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 109.9 K, Net Income 20.35 M, EPS -0.168

Jul3
IPO(CST)

Listing Price HKD 10.1

Jun23
Earning Release(CST)

FY2024 Annual Earning Release (HKD) Revenue 79.6 M, Net Income -772.56 M, EPS -1.6251

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
00312
0.081
+68.75%
+0.033
01271
1.270
+45.98%
+0.400
00191
0.720
+44.00%
+0.220
01725
1.000
+42.86%
+0.300
01045
3.740
+34.53%
+0.960
08460
3.000
+32.74%
+0.740
00498
0.155
+29.17%
+0.035
02478
1.620
+26.56%
+0.340
08429
0.070
+25.00%
+0.014
08311
0.098
+24.05%
+0.019
View More